- Report
- May 2025
- 199 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- August 2024
- 140 Pages
Global
From €2645EUR$2,999USD£2,281GBP
- Report
- April 2025
- 120 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 272 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- July 2025
- 183 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 497 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- July 2025
- 378 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- January 2025
- 148 Pages
Global
From €2787EUR$3,160USD£2,404GBP
€3484EUR$3,950USD£3,005GBP
- Report
- October 2021
- 61 Pages
Global
From €4365EUR$4,950USD£3,765GBP
- Report
- February 2024
- 130 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- April 2024
- 160 Pages
Global
From €4382EUR$4,969USD£3,780GBP
- Report
- February 2024
- 180 Pages
Global
From €4382EUR$4,969USD£3,780GBP
- Report
- February 2024
- 120 Pages
Global
From €4189EUR$4,750USD£3,613GBP
- Report
- December 2022
- 189 Pages
Africa, Middle East
From €3043EUR$3,450USD£2,624GBP

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord. It is characterized by muscle weakness, difficulty speaking, and difficulty swallowing. As the disease progresses, it can lead to paralysis and eventually death. Treatment options are limited and there is no cure.
The ALS market is a subset of the larger neurology market. It is a growing market, driven by increasing awareness of the disease and the development of new treatments. There is a need for more effective treatments and therapies to improve the quality of life for those living with ALS.
Companies in the ALS market include Biogen, Novartis, Sanofi, and Teva Pharmaceuticals. These companies are developing treatments and therapies to improve the lives of those living with ALS. Show Less Read more